MiRNA-128-3p of targeting Galectin-3 gene and use of miRNA-128-3p to resistance of pancreatic cancer

The invention discloses miRNA-128-3p of targeting a Galectin-3 gene. A sense strand of the miRNA-128-3p is 5'-CACUAGAUUGUGAGCUCCUGGA-3', and an antisense strand of the miRNA-128-3p is 5'-UCCAGGAGCUCACAAUCUAGUG-3'. The invention further discloses a drug carrier for the miRNA-128-3...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: XUAN SHIHAI, XIE XUDONG, LI MEI, LU CUIHUA, XIAO MINGBING, JIANG FENG, PAN LINGLING, WANG ZHENGDONG, CHEN FEI
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention discloses miRNA-128-3p of targeting a Galectin-3 gene. A sense strand of the miRNA-128-3p is 5'-CACUAGAUUGUGAGCUCCUGGA-3', and an antisense strand of the miRNA-128-3p is 5'-UCCAGGAGCUCACAAUCUAGUG-3'. The invention further discloses a drug carrier for the miRNA-128-3p of targeting the Galectin-3 gene, and the drug carrier is an exosome (EXO) derived from human umbilical cord mesenchymal stem cells (HUCMSCs). In addition, the invention further discloses experimental verification of use of the miRNA-128-3p, carried by the HUCMSCs exosome, of targeting the Galectin-3 gene to resistance of the pancreatic cancer. According to the embodiments of the invention, miRNA-128-3p mimic is successfully transfected to a neonatal umbilical cord tissue-derived HUCMSCs-EXO to construct an engineered EXO; and the engineered EXO can inhibit migration, invasion and proliferation of pancreatic cancer cells by targeting Galectin-3. 本发明公开一种靶向Galectin-3基因的miRNA-128-3p,所述miRNA-128-3p的正义链:5'-CACUAGAUUGUGAGCUCCUGGA-3',其反义链: